Header Logo

Connection

NANBING LI-VILLARREAL to Biomarkers, Tumor

Back to Details
This is a "connection" page, showing publications NANBING LI-VILLARREAL has written about Biomarkers, Tumor.
NANBING LI-VILLARREAL
Connection Strength
0.156
Biomarkers, Tumor
  1. Mutant LKB1 Confers Enhanced Radiosensitization in Combination with Trametinib in KRAS-Mutant Non-Small Cell Lung Cancer. Clin Cancer Res. 2018 11 15; 24(22):5744-5756.
    View in: PubMed
    Score: 0.080
  2. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy for Resected Non-small Cell Lung Cancer. Clin Cancer Res. 2018 01 15; 24(2):341-350.
    View in: PubMed
    Score: 0.076
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.